If any of the following apply to you, it's worth discussing them with your healthcare provider before starting or continuing the medication: A prior history of pancreatitis: Having had pancreatitis before is one of the most significant risk factors for developing it again, regardless of the trigger
Product information: Download the safety data sheet Product use Scientific research, laboratory analysis, reference material / test standard
Dempsey reported that the GLP-1 agonist Zepbound removed the high intracranial pressure in one patient
These typically decrease as the body adjusts
They may support brighter and even-toned skin by reducing oxidative damage, but results vary and are not guaranteed for everyone
The literature also describes upregulation of growth factors involved in tissue repair, modulation of nitric oxide synthase activity, and effects on the dopaminergic and serotonergic systems that are harder to interpret clinically [Sikiric et al., Inflammopharmacology, 2018]